High incidence of skin rash in patients with hairy cell leukemia treated with cladribine

Leukemia and Lymphoma

Volumn 53, Issue 6, 2012, Pages 1169-1173

  Ganzel, Chezi ^a   Gatt, Moshe E ^a   Maly, Alexander ^a   Ben Yehuda, Dina ^a   Goldschmidt, Neta ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cladribine (2 chlorodeoxyadenosine 2 CdA); Drug hypersensitivity; Hairy cell leukemia; Lymphopenia

Indexed keywords

CLADRIBINE; PENICILLIN G; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; FEBRILE NEUTROPENIA; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; INCIDENCE; LYMPHOCYTE COUNT; MALE; MULTIPLE CYCLE TREATMENT; PATIENT CARE; PRIORITY JOURNAL; RASH; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CLADRIBINE; EXANTHEMA; FEMALE; HUMANS; INCIDENCE; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 84861350002     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.635864     Document Type: Article

References (37)

1. Grever MR. How I treat hairy cell leukemia. Blood 2010;115:21-28.
2. Quesada JR, Reuben J, Manning JT, et al. Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med 1984;310:15-18. (Pubitemid 14212475)
3. Spiers AS, Parekh SJ, Bishop MB. Hairy-cell leukemia: induction of complete remission with pentostatin (2 ' -deoxycoformycin). J Clin Oncol 1984;2:1336-1342. (Pubitemid 15179534)
4. Piro LD, Carrera CJ, Carson DA, et al. Lasting remissions in hairycell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117-1121. (Pubitemid 20149529)
5. Goodman GR, Burian C, Koziol JA, et al. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21:891-896. (Pubitemid 46606450)
6. Saven A, Burian C, Koziol JA, et al. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998;92:1918-1926. (Pubitemid 28446680)
7. Urba WJ, Baseler MW, Kopp WC, et al. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia. Blood 1989;73:38-46. (Pubitemid 19040951)
8. Seymour JF, Kurzrock R, Freireich EJ, et al. 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4 + lymphocyte counts in patients with hairy cell leukemia. Blood 1994;83:2906-2911. (Pubitemid 24142723)
9. Juliusson G, Lenkei R, Liliemark J. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine. Blood 1994;83:3672-3681. (Pubitemid 24175558)
10. Tallman MS, Hakimian D, Variakojis D, et al. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 1992;80:2203-2209.
11. Meunier P, Castaigne S, Bastie JN, et al. Cutaneous reactions after treatment with 2-chlorodeoxyadenosine. Acta Derm Venereol 1996;76:385-386. (Pubitemid 26297985)
12. Grey MR, Flanagan NG, Kelsey PR. Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution. Clin Lab Haematol 2000;22: 111-113. (Pubitemid 30331286)
13. Hendrick A. Purpuric rash following treatment with 2- chlorodeoxyadenosine. Clin Lab Haematol 2001;23:67-68. (Pubitemid 32588417)
14. Chubar Y, Bennett M. Cutaneous reactions in hairy cell leukaemia treated with 2-chlorodeoxyadenosine and allopurinol. Br J Haematol 2003;122:768-770. (Pubitemid 37100302)
15. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003;139:683-693.
16. Emmerson BT, Hazelton RA, Frazer IH. Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol. Arthritis Rheum 1988;31:436-440. (Pubitemid 18091669)
17. Solensky R. Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev Allergy Immunol 2003;24:201-220.
18. McInnes GT, Lawson DH, Jick H. Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis 1981;40:245-249. (Pubitemid 11122536)
19. Jick H. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis 1982;4:426-428.
20. Seymour JF, Talpaz M, Kurzrock R. Response duration and recovery of CD4 + lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up. Leukemia 1997;11:42-47. (Pubitemid 27065048)
21. Kraut EH, Neff JC, Bouroncle BA, et al. Immunosuppressive Effects of pentostatin. J Clin Oncol 1990;8:848-855. (Pubitemid 20148277)
22. Rafel M, Cervantes F, Beltran JM, et al. Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients. Cancer 2000;88:352-357. (Pubitemid 30051819)
23. Johnston JB, Glazer RI, Pugh L, et al. The treatment of hairy-cell leukaemia with 2 ' -deoxycoformycin. Br J Haematol 1986;63:525-534.
24. Cook S, Vermersch P, Comi G, et al. Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study. Mult Scler 2011;17: 578-593.
25. Coopman SA, Johnson RA, Platt R, et al. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993;328:1670-1674. (Pubitemid 23157349)
26. Jappe U. Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation? Allergy 2007;62:1474-1475. (Pubitemid 350045594)
27. Wharton JM, Coleman DL, Wofsy CB, et al. Trimethoprimsulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodefi ciency syndrome. A prospective randomized trial. Ann Intern Med 1986;105:37-44. (Pubitemid 16097919)
28. Patel BM. Skin rash with infectious mononucleosis and ampicillin. Pediatrics 1967;40:910-911.
29. Saven A, Burian C, Adusumalli J, et al. Filgrastim for cladribineinduced neutropenic fever in patients with hairy cell leukemia. Blood 1999;93:2471-2477. (Pubitemid 29181177)
30. Juliusson G, Lenkei R, Tjonnfjord G, et al. Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and Effects of granulocyte-macrophage colonystimulating factor. Ann Oncol 1995;6:371-375.
31. Yoshizawa S, Yasuoka A, Kikuchi Y, et al. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodefi ciency virus type-1 infection who were previously intolerant to T/S. Ann Allergy Asthma Immunol 2000;85:241-244. (Pubitemid 32098541)
32. Cernadas JR, Brockow K, Romano A, et al. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010;65:1357-1366.
33. Robak T, Blasinska-Morawiec M, Krykowski E. Transient eosinophilia in a patient with hairy-cell leukaemia treated with 2-chlorodeoxyadenosine. Acta Haematol Pol 1992;23:285-290. (Pubitemid 23021671)
34. Robak T, Sysa-Jedrzejowska A, Robak E, et al. 2-Chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemia. J Med 1997;28:199-209. (Pubitemid 27464917)
35. Robak T, Blasinska-Morawiec M, Krykowski E, et al. 2-Chlorodeoxyadenosine (cladribine)-related eosinophilia in patients with lymphoproliferative diseases. Eur J Haematol 1997;59:216-220. (Pubitemid 27425463)
36. Rutella S, Sica S, Rumi C, et al. Hypereosinophilia during 2-chlorodeoxyadenosine treatment for hairy cell leukaemia. Br J Haematol 1996;92:426-428. (Pubitemid 26042939)
37. Larfars G, Uden-Blohme AM, Samuelsson J. Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies. Br J Haematol 1996;94:709-712. (Pubitemid 26308907)